Preoperative lymphocyte count in relation to sarcoma prognosis.

Soon Teck Seo Vivek Ajit SinghNor Faissal Yasin

Published in: Journal of orthopaedic surgery (Hong Kong) (2020)

LMR and NLR can be used to identify patients at risk for poor clinical outcome, so that a more aggressive course of treatment can be applied to improve outcome. These are cost-effective prognostic tools as they are calculated from routine preoperative peripheral blood counts. In conclusion, preoperative NLR and LMR are good prognostic markers for predicting the clinical outcome of patients with sarcoma.

Keyphrases

peripheral blood
patients undergoing
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
patient reported outcomes
smoking cessation